DK0678088T3 - N-acylpyrrolidiner og lægemidler til behandling og forebyggelse af cholecystokinin- og gastrinrelaterede sygdomme - Google Patents
N-acylpyrrolidiner og lægemidler til behandling og forebyggelse af cholecystokinin- og gastrinrelaterede sygdommeInfo
- Publication number
- DK0678088T3 DK0678088T3 DK94903939.0T DK94903939T DK0678088T3 DK 0678088 T3 DK0678088 T3 DK 0678088T3 DK 94903939 T DK94903939 T DK 94903939T DK 0678088 T3 DK0678088 T3 DK 0678088T3
- Authority
- DK
- Denmark
- Prior art keywords
- gastrin
- pct
- acylpyrrolidines
- cholecystokinin
- drugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9300077A FR2700165B1 (fr) | 1993-01-07 | 1993-01-07 | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0678088T3 true DK0678088T3 (da) | 1996-11-18 |
Family
ID=9442866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94903939.0T DK0678088T3 (da) | 1993-01-07 | 1994-01-03 | N-acylpyrrolidiner og lægemidler til behandling og forebyggelse af cholecystokinin- og gastrinrelaterede sygdomme |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5624939A (ru) |
| EP (1) | EP0678088B1 (ru) |
| JP (1) | JPH08505614A (ru) |
| KR (1) | KR960700228A (ru) |
| AT (1) | ATE143946T1 (ru) |
| AU (1) | AU5819294A (ru) |
| CA (1) | CA2152281A1 (ru) |
| DE (1) | DE69400702T2 (ru) |
| DK (1) | DK0678088T3 (ru) |
| ES (1) | ES2094048T3 (ru) |
| FR (1) | FR2700165B1 (ru) |
| GR (1) | GR3021313T3 (ru) |
| HU (1) | HUT74095A (ru) |
| IL (1) | IL108290A0 (ru) |
| NO (1) | NO952559L (ru) |
| NZ (1) | NZ259398A (ru) |
| RU (1) | RU95116448A (ru) |
| WO (1) | WO1994015914A1 (ru) |
| ZA (1) | ZA9480B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2721608B1 (fr) * | 1994-06-22 | 1996-07-19 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
| FR2744362B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
| FR2744361B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
| TW442449B (en) | 1996-07-04 | 2001-06-23 | Hoechst Ag | Process for preparing 1,2-dichloroethane by direct chlorination |
| DE10218377B4 (de) * | 2002-04-25 | 2004-03-11 | Rea Gesellschaft Für Recycling Von Energie Und Abfall Mbh | Verfahren und Vorrichtung zur Schwerstoffabtrennung aus Aufschlämmungen |
| US8247438B2 (en) | 2008-02-27 | 2012-08-21 | Neuropill, Inc. | Methods for treating schizophrenia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3481913D1 (de) * | 1983-04-27 | 1990-05-17 | Ici America Inc | Prolin-derivate. |
| FR2667864B2 (fr) * | 1990-03-07 | 1994-08-05 | Rhone Poulenc Sante | Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant. |
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
-
1993
- 1993-01-07 FR FR9300077A patent/FR2700165B1/fr not_active Expired - Fee Related
-
1994
- 1994-01-03 HU HU9502067A patent/HUT74095A/hu unknown
- 1994-01-03 RU RU95116448/04A patent/RU95116448A/ru unknown
- 1994-01-03 US US08/448,406 patent/US5624939A/en not_active Expired - Fee Related
- 1994-01-03 AT AT94903939T patent/ATE143946T1/de not_active IP Right Cessation
- 1994-01-03 DE DE69400702T patent/DE69400702T2/de not_active Expired - Fee Related
- 1994-01-03 WO PCT/FR1994/000008 patent/WO1994015914A1/fr active IP Right Grant
- 1994-01-03 ES ES94903939T patent/ES2094048T3/es not_active Expired - Lifetime
- 1994-01-03 NZ NZ259398A patent/NZ259398A/en unknown
- 1994-01-03 EP EP94903939A patent/EP0678088B1/fr not_active Expired - Lifetime
- 1994-01-03 DK DK94903939.0T patent/DK0678088T3/da active
- 1994-01-03 CA CA002152281A patent/CA2152281A1/fr not_active Abandoned
- 1994-01-03 JP JP6515747A patent/JPH08505614A/ja active Pending
- 1994-01-03 KR KR1019950702823A patent/KR960700228A/ko not_active Application Discontinuation
- 1994-01-03 AU AU58192/94A patent/AU5819294A/en not_active Abandoned
- 1994-01-06 IL IL10829094A patent/IL108290A0/xx unknown
- 1994-01-06 ZA ZA9480A patent/ZA9480B/xx unknown
-
1995
- 1995-06-26 NO NO952559A patent/NO952559L/no unknown
-
1996
- 1996-10-10 GR GR960401619T patent/GR3021313T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994015914A1 (fr) | 1994-07-21 |
| NO952559D0 (no) | 1995-06-26 |
| DE69400702D1 (de) | 1996-11-14 |
| EP0678088A1 (fr) | 1995-10-25 |
| CA2152281A1 (fr) | 1994-07-21 |
| JPH08505614A (ja) | 1996-06-18 |
| ES2094048T3 (es) | 1997-01-01 |
| EP0678088B1 (fr) | 1996-10-09 |
| GR3021313T3 (en) | 1997-01-31 |
| IL108290A0 (en) | 1994-04-12 |
| NZ259398A (en) | 1996-02-27 |
| FR2700165B1 (fr) | 1995-02-17 |
| KR960700228A (ko) | 1996-01-19 |
| ZA9480B (en) | 1994-08-11 |
| US5624939A (en) | 1997-04-29 |
| NO952559L (no) | 1995-06-26 |
| AU5819294A (en) | 1994-08-15 |
| HU9502067D0 (en) | 1995-09-28 |
| DE69400702T2 (de) | 1997-03-06 |
| ATE143946T1 (de) | 1996-10-15 |
| FR2700165A1 (fr) | 1994-07-08 |
| HUT74095A (en) | 1996-11-28 |
| RU95116448A (ru) | 1997-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| FI960399A (fi) | Perhydroisoindolijohdannaisia P-aineen antagonisteina | |
| FI932229A0 (fi) | Azabicykliska bryggderivat | |
| FI964772A0 (fi) | (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa | |
| DK0752854T3 (da) | Pyrimidin- eller triazincarboxylsyrederivater til anvendelse som lægemiddel | |
| DK0711283T3 (da) | Tetrahydro-1H-benzazepinoner og hexahydroazepinoner som selektive cholecystokinin-B-receptorantagonister | |
| DE69511544D1 (de) | Amidderivate und ihre therapeutische verwendung | |
| DK0748314T3 (da) | Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
| SE8701375D0 (sv) | Novel pyridyl- and pyrimidyl derivatives | |
| DK0678088T3 (da) | N-acylpyrrolidiner og lægemidler til behandling og forebyggelse af cholecystokinin- og gastrinrelaterede sygdomme | |
| DK0678089T3 (da) | N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser | |
| ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
| NZ320522A (en) | Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds | |
| DK0766695T3 (da) | Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme | |
| ES2140544T3 (es) | Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas. | |
| DK0737187T3 (da) | Benzoxazinderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemidler | |
| DK0729469T3 (da) | Imidazo[1,5-a]quinoliner til behandling af angst og søvnforstyrrelser | |
| MX9306879A (es) | Derivados de piperazina y composiciones farmaceuticas que los contienen,para el tratamiento de enfermedades del conocimiento. |